BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 27137880)

  • 1. Causes of death and life span in Finnish gelsolin amyloidosis.
    Schmidt EK; Atula S; Tanskanen M; Nikoskinen T; Notkola IL; Kiuru-Enari S
    Ann Med; 2016 Aug; 48(5):352-8. PubMed ID: 27137880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gender differences in the clinical course of Finnish gelsolin amyloidosis.
    Atula S; Nikoskinen T; Saastamoinen A; Strbian D; Schmidt EK; Kiuru-Enari S
    Amyloid; 2016; 23(1):33-8. PubMed ID: 26805765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Finnish gelsolin amyloidosis causes significant disease burden but does not affect survival: FIN-GAR phase II study.
    Schmidt EK; Mustonen T; Kiuru-Enari S; Kivelä TT; Atula S
    Orphanet J Rare Dis; 2020 Jan; 15(1):19. PubMed ID: 31952544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Neurological manifestations of AGel amyloidosis (Meretoja's syndrome) in a German family].
    Bürmann J; Fassbender K; Henn W; Lohse P; Holzhoffer C; Fassbender K; Dillmann U
    Fortschr Neurol Psychiatr; 2011 Apr; 79(4):238-41. PubMed ID: 21480154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural course of Finnish gelsolin amyloidosis.
    Nikoskinen T; Schmidt EK; Strbian D; Kiuru-Enari S; Atula S
    Ann Med; 2015; 47(6):506-11. PubMed ID: 26339870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutis laxa in hereditary gelsolin amyloidosis.
    Kiuru-Enari S; Keski-Oja J; Haltia M
    Br J Dermatol; 2005 Feb; 152(2):250-7. PubMed ID: 15727635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hereditary gelsolin amyloidosis--40 years of Meretoja disease].
    Kiuru-Enari S; Haltia M
    Duodecim; 2010; 126(10):1162-71. PubMed ID: 20597346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ocular amyloid deposition in familial amyloidosis, Finnish: an analysis of native and variant gelsolin in Meretoja's syndrome.
    Kivelä T; Tarkkanen A; Frangione B; Ghiso J; Haltia M
    Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3759-69. PubMed ID: 8088963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac manifestations in Finnish gelsolin amyloidosis patients.
    Mustonen T; Holkeri A; Holmström M; Atula S; Pakarinen S; Lehmonen L; Kiuru-Enari S; Aro AL
    Amyloid; 2021 Sep; 28(3):168-172. PubMed ID: 33877023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe ataxia with neuropathy in hereditary gelsolin amyloidosis: a case report.
    Tanskanen M; Paetau A; Salonen O; Salmi T; Lamminen A; Lindsberg P; Somer H; Kiuru-Enari S
    Amyloid; 2007 Mar; 14(1):89-95. PubMed ID: 17453628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common origin of the gelsolin gene variant in 62 Finnish AGel amyloidosis families.
    Mustonen T; Schmidt EK; Valori M; Tienari PJ; Atula S; Kiuru-Enari S
    Eur J Hum Genet; 2018 Jan; 26(1):117-123. PubMed ID: 29167514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amyloid in parenchymal organs in gelsolin (AGel) amyloidosis.
    Schmidt EK; Kiuru-Enari S; Atula S; Tanskanen M
    Amyloid; 2019 Sep; 26(3):118-124. PubMed ID: 31122115
    [No Abstract]   [Full Text] [Related]  

  • 13. Xerostomia in hereditary gelsolin amyloidosis.
    Juusela P; Tanskanen M; Nieminen A; Kari K; Suominen L; Uitto VJ; Kiuru-Enari S
    Amyloid; 2013 Mar; 20(1):39-44. PubMed ID: 23356404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hereditary gelsolin amyloidosis.
    Kiuru-Enari S; Haltia M
    Handb Clin Neurol; 2013; 115():659-81. PubMed ID: 23931809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuromuscular pathology in hereditary gelsolin amyloidosis.
    Kiuru-Enari S; Somer H; Seppäläinen AM; Notkola IL; Haltia M
    J Neuropathol Exp Neurol; 2002 Jun; 61(6):565-71. PubMed ID: 12071640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanobody interaction unveils structure, dynamics and proteotoxicity of the Finnish-type amyloidogenic gelsolin variant.
    Giorgino T; Mattioni D; Hassan A; Milani M; Mastrangelo E; Barbiroli A; Verhelle A; Gettemans J; Barzago MM; Diomede L; de Rosa M
    Biochim Biophys Acta Mol Basis Dis; 2019 Mar; 1865(3):648-660. PubMed ID: 30625383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel gelsolin variant as the cause of nephrotic syndrome and renal amyloidosis in a large kindred.
    Efebera YA; Sturm A; Baack EC; Hofmeister CC; Satoskar A; Nadasdy T; Nadasdy G; Benson DM; Gillmore JD; Hawkins PN; Rowczenio D
    Amyloid; 2014 Jun; 21(2):110-2. PubMed ID: 24601799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Danish type gelsolin-related amyloidosis in a Brazilian family: case reports.
    Solari HP; Ventura MP; Antecka E; Belfort Junior R; Burnier MN
    Arq Bras Oftalmol; 2011; 74(4):286-8. PubMed ID: 22068858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe elastolysis in hereditary gelsolin (AGel) amyloidosis.
    Koskelainen S; Zhao F; Kalimo H; Baumann M; Kiuru-Enari S
    Amyloid; 2020 Jun; 27(2):81-88. PubMed ID: 31814469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing amount of amyloid are associated with the severity of clinical features in hereditary gelsolin (AGel) amyloidosis.
    Pihlamaa T; Suominen S; Kiuru-Enari S; Tanskanen M
    Amyloid; 2016 Dec; 23(4):225-233. PubMed ID: 27879149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.